What Heart Disease Looks Like in Senior Dogs
A dog's heart has four chambers working in concert: the left and right atria receive blood, the left and right ventricles pump it out. Between the left atrium and ventricle sits the mitral valve — a one-way seal that should close completely with every heartbeat. When that valve degenerates over time, blood leaks backward into the left atrium. The heart compensates by working harder, thickening its walls, then eventually dilating under sustained pressure. That compensation phase can last a long time, which is why early-stage disease often produces no obvious symptoms.
The most common acquired cardiac disease in dogs is degenerative mitral valve disease (DMVD), which accounts for roughly 75% of all canine heart disease cases. Small and toy breeds are disproportionately affected, with Cavalier King Charles Spaniels, Chihuahuas, Yorkshire Terriers, Dachshunds, Toy Poodles, and Maltese carrying the highest risk. Large and giant breeds face a different threat: dilated cardiomyopathy (DCM), in which the ventricle walls thin and the heart chamber enlarges rather than thickening. Breeds including Doberman Pinschers, Great Danes, Boxers, Irish Wolfhounds, and Newfoundlands are most vulnerable to DCM. Both conditions are progressive, irreversible, and responsive to treatment — which is why early detection matters so much.
The ACVIM Staging System: Why It Matters
Veterinary cardiologists classify heart disease into four stages, and understanding them directly shapes treatment decisions:
- Stage A — At-risk dogs. No murmur, no symptoms. Small breeds over age 7 and large breeds with known hereditary risk fall here. Annual stethoscope screening is the only intervention warranted.
- Stage B — A murmur is detectable, but the dog shows no symptoms. Subdivided into B1 (no cardiac enlargement on imaging) and B2 (measurable chamber enlargement). Evidence strongly supports starting Pimobendan in Stage B2 before symptoms develop — the EPAP study and follow-up trials showed significant delays in heart failure onset and longer survival with early Pimobendan use.
- Stage C — Current or past heart failure symptoms: cough, labored breathing, exercise intolerance, or fluid accumulation. Standard therapy is Pimobendan, an ACE inhibitor, and a diuretic such as Furosemide.
- Stage D — End-stage disease no longer controlled by standard treatment. Requires escalating doses, additional medications, and candid conversations about quality of life.
The staging framework exists to match treatment intensity to disease severity — and to prevent under-treatment in early stages where intervention makes the most difference.
Warning Signs: What Actually Shows Up at Home
Senior dogs are skilled at masking discomfort, and early cardiac changes often look like ordinary aging. The dogs who get diagnosed at Stage B rather than Stage C are almost always the ones whose owners noticed subtle shifts others might have dismissed.
Exercise intolerance is the most consistent early clue. A dog that previously kept up on a long walk but now lags after a short distance, lies down repeatedly, or seems to fatigue unusually quickly — these changes warrant veterinary attention. The key differentiator from arthritis: cardiac exercise intolerance causes rapid, labored breathing disproportionate to the activity. Arthritic dogs slow down but typically breathe normally for the exertion level. Our osteoarthritis guide covers joint pain signs in more detail for comparison.
A soft, persistent cough that worsens at night or first thing in the morning is a cardiac red flag. Fluid building up in the lungs from heart failure presses on airways and triggers a cough reflex. This cough does not respond to standard cough suppressants and often persists for weeks before owners connect it to the heart. Any cough lasting more than two weeks without a clear respiratory explanation calls for a chest X-ray — not just a physical exam.
Resting respiratory rate is measurable at home. Normal is 10–30 breaths per minute. Track it in the morning before any activity — record it for a week to establish your dog's personal baseline. Sustained readings above 35 breaths per minute across multiple days, without an obvious trigger like heat or excitement, warrant same-day veterinary evaluation.
Gum color and capillary refill time are underused home monitoring tools. Healthy gums are pink. Blue or purplish gums indicate oxygen deprivation and require emergency care. Press a finger against the gum — it should blanch white and return to pink within two seconds. Delayed refill is another urgent signal. Check this monthly alongside other senior dog health monitoring habits.
Labored breathing at rest, a visibly distended abdomen, profound lethargy, or collapse indicate advanced heart failure and require immediate veterinary intervention.
Which Dogs Are at Highest Risk
Degenerative mitral valve disease has a well-established breed pattern. Nearly 100% of Cavalier King Charles Spaniels develop a heart murmur by age 10, with faster disease progression than any other breed. Chihuahuas, Yorkshire Terriers, Toy and Miniature Poodles, Maltese, Dachshunds, and Shih Tzus all carry elevated risk. For these breeds, annual cardiac auscultation should begin by age 5 — not age 8, which is too late for early intervention.
Large breed owners face a different risk profile. Dilated cardiomyopathy in Doberman Pinschers affects approximately 40–50% of the breed, and DCM in Dobermans often produces no preceding murmur. The Doberman Pinscher Club of America recommends annual echocardiogram and 24-hour Holter monitor testing starting at age 3 for this breed. Great Danes, Boxers, Irish Wolfhounds, and Newfoundlands also carry elevated DCM risk and benefit from breed-specific screening protocols.
Mixed-breed dogs are not immune. While some data suggests lower cardiac disease incidence in mixed breeds, any senior dog — regardless of ancestry — deserves annual cardiac auscultation as part of comprehensive senior wellness care, especially when concurrent conditions like thyroid dysfunction or kidney disease are present.
How Vets Diagnose Heart Disease: Making Sense of the Tests
Stethoscope exam is the entry point. A heart murmur — turbulent blood flow through a leaking valve — is the primary finding that triggers further investigation. Murmurs are graded I through VI. A Grade I-II murmur in an older small breed dog is a signal to monitor every six months, not to ignore. Louder murmurs generally indicate more significant leakage, but loudness does not perfectly correlate with disease severity — imaging is required for proper staging.
Chest X-ray is the most useful initial imaging test. It reveals heart size using the vertebral heart scale, shows fluid in the lung fields (pulmonary edema), and identifies fluid around the lungs (pleural effusion). X-rays are widely available, relatively affordable, and produce immediately actionable information. A vertebral heart score above 10.5 in most breeds indicates meaningful cardiac enlargement.
Echocardiogram (cardiac ultrasound) is the definitive test. It measures chamber dimensions, valve morphology, ejection fraction, and the severity of mitral regurgitation. It distinguishes DMVD from DCM and provides the imaging data needed for accurate ACVIM staging. This test requires a veterinary cardiologist and specialized equipment.
NT-proBNP blood test measures a biomarker that indicates cardiac strain. Elevated levels suggest meaningful cardiac stress even before clinical signs appear. It is useful for screening dogs with a murmur where imaging has not yet been done, or as a baseline for tracking change over time. It complements — does not replace — imaging and auscultation.
Baseline bloodwork before starting any cardiac medication is essential. ACE inhibitors and Pimobendan can affect kidney function; establishing baseline creatinine, BUN, and electrolyte values before treatment begins is standard of care and necessary for safe long-term monitoring.
Treatment: What the Evidence Supports
Pimobendan (Vetmedin) is the most impactful cardiac medication for dogs with DMVD and symptomatic disease. It works through calcium sensitization — making the heart muscle contract more efficiently — and PDE-III inhibition, which dilates blood vessels and reduces cardiac workload. The evidence for Pimobendan in Stage B2 onward is robust. Start it when your cardiologist confirms cardiac enlargement, not when symptoms appear.
ACE inhibitors (Enalapril, Benazepril) reduce afterload by dilating arteries, making it easier for the heart to pump forward. They are indicated in symptomatic heart disease and generally well-tolerated. Check renal values 7–14 days after initiation — a modest creatinine or BUN rise is expected; a significant rise warrants dose adjustment.
Furosemide (Lasix) is a diuretic that removes fluid from the lungs. It treats pulmonary edema and symptomatic heart failure — it is not used pre-symptomatically. Using diuretics before fluid has accumulated is counterproductive: they reduce cardiac output and can accelerate disease progression in early stages.
Spironolactone is a potassium-sparing diuretic with anti-fibrotic properties. When added to standard Pimobendan plus ACE inhibitor therapy in symptomatic dogs, evidence suggests a modest survival benefit. Low side-effect profile makes it a common third-line addition. Our medication management guide covers safe protocols for multi-drug regimens in senior dogs.
Daily Life With a Dog Who Has Heart Disease
Weight management is one of the most powerful tools owners have. Every excess pound increases cardiac workload. Lean body condition (BCS 4–5 on a 9-point scale) measurably reduces respiratory effort and improves exercise tolerance in early-stage disease. This is especially important for dogs also managing concurrent arthritis pain, since joint inflammation compounds cardiovascular stress.
Sleeping respiratory rate is the most actionable home monitoring metric for any dog with diagnosed heart disease. Record it at the same time each morning using a phone video. Below 30 is normal. Sustained readings above 35 across three or more consecutive days — without an obvious trigger — warrant a call to your veterinary team. This habit has saved the lives of countless dogs by catching pulmonary edema before a crisis develops.
Dietary sodium requires nuance. In symptomatic heart failure, low-sodium diets reduce fluid retention. In early-stage disease (Stage B), severe sodium restriction is not clearly beneficial and may inadvertently activate the renin-angiotensin-aldosterone system, potentially accelerating disease. Practical advice: avoid high-sodium treats like cheese and processed meats. Feed a balanced diet without added salt. Do not restrict dietary sodium in pre-symptomatic dogs without specific veterinary guidance.
Stress and heat management matters at all stages but becomes critical in Stage C and D. Heat, excitement, and strenuous activity all increase cardiac demand. Controlled leash walks without free running, a cool living environment, and a consistent calm routine reduce symptom flare-ups. Managing cognitive decline alongside cardiac disease adds complexity — changes in sleeping patterns, disorientation, or anxiety can elevate stress and cardiac workload simultaneously.
Quality of Life and Long-Term Outlook
The honest prognosis for a dog diagnosed in Stage B and started on appropriate treatment is measured in years — not months. Dogs receiving Pimobendan from Stage B2 consistently live significantly longer and experience fewer heart failure crises than dogs started on treatment only after symptoms appear.
At Stage C, outcomes are more variable. Good management can maintain quality of life for 12–24 months or longer with attentive home care and regular veterinary monitoring. At Stage D, the goal shifts toward comfort — recognizing when escalating treatment burden no longer translates to meaningful quality of life for the dog.
Heart disease rarely arrives alone in senior dogs. Cushing's disease increases cardiac strain through cortisol-driven hypertension. Thyroid dysfunction disrupts metabolic rate in ways that compound cardiac stress. Kidney disease and heart disease share bidirectional risk factors and complicate medication choices. For dogs managing multiple conditions simultaneously, coordinated care and honest conversations about competing priorities become essential. Our quality of life scale offers a structured way to evaluate wellbeing across multiple dimensions for dogs with complex medical needs.
Frequently Asked Questions
When should I start screening my dog for heart disease?
Small breed dogs over age 7 should have annual cardiac auscultation. Breeds with high DMVD prevalence — Cavalier King Charles Spaniels, Chihuahuas, Yorkies — should begin by age 5. Large breeds with hereditary cardiac risk should have baseline assessment by age 3–5. Our senior wellness exam guide covers what a comprehensive geriatric checkup includes.
Can heart disease in dogs be cured?
No. Degenerative mitral valve disease and dilated cardiomyopathy are both progressive and irreversible. Treatment slows disease progression, manages symptoms, and extends good-quality life — it does not eliminate the underlying disease. The value of early intervention is maximizing the number of years your dog spends free from symptoms before treatment is needed.
Is a heart murmur a sign my dog is dying?
No. Many dogs live with a heart murmur for years with excellent quality of life. The murmur indicates valvular leakage — what matters is whether it is progressing, whether imaging shows cardiac enlargement, and whether symptoms are developing. Staging through imaging, not just auscultation, is the proper approach to understanding what a murmur means for your individual dog.
How long can a dog live with heart disease?
Highly variable. Dogs diagnosed at Stage B2 with appropriate treatment routinely live 2–4+ years with good quality of life. Dogs diagnosed at Stage C with diligent management may have 12–24 months. These are ranges, not certainties — individual outcomes depend on disease type, breed, response to medication, concurrent conditions, and quality of home care.
What does quality of life look like in advanced heart failure?
Labored breathing even at rest, fluid-distended abdomen, profound exercise intolerance, coughing that disrupts sleep, and collapse episodes. When these signs are present despite optimal medical management, the conversation shifts from disease treatment to end-of-life care. Our guide to end-of-life decisions covers this topic with the honesty it deserves.